Pharmagreen Biotech

(OTC) PHBI

Current Price$0.00

Market Cap$622.20K

Since IPO (2018)-100%

5 Year-96%

1 Year+0%

1 Month-10%

Pharmagreen Biotech Financials at a Glance

Market Cap

$622.20K

Revenue (TTM)

$4.33M

Net Income (TTM)

-$1.26M

EPS (TTM)

-$0.00

P/E Ratio

-2.25

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$0.00

Volume

52,366

Open

$0.00

Price

$0.00

Volume

52,366

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

May 11, 2026

Dividend

$0.00

Beta (Volatility)

0.63 (Low)

Price

$0.00

Volume

52,366

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

May 11, 2026

PHBI News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Pharmagreen Biotech

Industry

Pharmaceuticals

Sector

Health Care

CEO

Peter Wojcik

Website

www.pharmagreen.ca

Headquarters

Coquitlam, BC V3E 3A2, CA

PHBI Financials

Key Financial Metrics (TTM)

Gross Margin

-0.02%

Operating Margin

-29.70%

Net Income Margin

-28.96%

Return on Equity

21.12%

Return on Capital

N/A

Return on Assets

-152.64%

Earnings Yield

-44.44%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$622.20K

Shares Outstanding

691.35M

Volume

52.37K

Avg. Volume

2.29M

Financials (TTM)

Gross Profit

-$1.02K

Operating Income

-$1.29M

EBITDA

-$1.26M

Operating Cash Flow

-$19.00K

Capital Expenditure

-$3.00

Free Cash Flow

-$19.01K

Cash & ST Invst.

$234.69K

Total Debt

$266.07K

Pharmagreen Biotech Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$911.70K

+110008.6%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$622.20K

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$65.14K

-110.3%

EBITDA

-$66.27K

-110.3%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$234.69K

+25804.1%

Total Debt

$266.07K

-24.5%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$266.07K

+0.8%

Return on Assets

-1.53%

N/A

Return on Invested Capital

13.67%

N/A

Free Cash Flow

-$3.82K

-487.7%

Operating Cash Flow

-$3.82K

-484.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MJNAMedical Marijuana, Inc.

MJNAMedical Marijuana, Inc.$0.00-50.00%

CBDYTarget Group Inc.

CBDYTarget Group Inc.$0.00+0.00%

MSTHMystic Holdings, Inc.

MSTHMystic Holdings, Inc.$0.00+0.00%

ALIDAllied Corp.

ALIDAllied Corp.$0.00+0.00%

SRUTFSproutly Canada Inc.

SRUTFSproutly Canada Inc.$0.00+0.00%

APPBApplied Biosciences Corp.

APPBApplied Biosciences Corp.$0.00+0.00%

CPMDCannaPharmaRX, Inc.

CPMDCannaPharmaRX, Inc.$0.00+15.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TAT&T

TAT&T$20.58+0.00%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

Questions About PHBI

What is the current price of Pharmagreen Biotech?

Pharmagreen Biotech is trading at $0.00 per share.

What is the 52-week range for Pharmagreen Biotech?

Over the past 52 weeks, Pharmagreen Biotech has traded between $0.00 and $0.00.

How much debt does Pharmagreen Biotech have?

As of the most recent reporting period, Pharmagreen Biotech reported total debt of $266.07K.

How much cash does Pharmagreen Biotech have on hand?

Pharmagreen Biotech reported $234.69K in cash and cash equivalents in its most recent financial results.

What is Pharmagreen Biotech’s dividend yield?

Pharmagreen Biotech does not currently have a dividend yield.

Pharmagreen Biotech

Pharmagreen Biotech Financials at a Glance

PHBI News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Pharmagreen Biotech

PHBI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Pharmagreen Biotech Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PHBI

What is the current price of Pharmagreen Biotech?

What is the 52-week range for Pharmagreen Biotech?

How much debt does Pharmagreen Biotech have?

How much cash does Pharmagreen Biotech have on hand?

What is Pharmagreen Biotech’s dividend yield?

Premium Investing Services